1
|
Stephens H, Deans C, Schlect D, Kairn T. Development of a method for treating lower-eyelid carcinomas using superficial high dose rate brachytherapy. Phys Eng Sci Med 2020; 43:1317-1325. [PMID: 33123861 DOI: 10.1007/s13246-020-00935-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2020] [Accepted: 10/03/2020] [Indexed: 11/26/2022]
Abstract
In this study, a method was developed for delivering high dose rate (HDR) brachytherapy treatments to basal cell carcinomas (BCCs) as well as squamous cell carcinomas (SCCs) of the lower eyelid via superficial catheters. Clinically-realistic BCC/SCC treatment areas were marked in the lower-eyelid region on a head phantom and several arrangements of catheters and bolus were trialled for treating those areas. The use of one or two catheters of different types was evaluated, and sources of dosimetric uncertainty (including air gaps) were evaluated and mitigated. Test treatments were planned for delivery with an iridium-192 source, using the Oncentra Brachy treatment planning system (Elekta AB, Stockholm, Sweden). Dose distributions were evaluated using radiochromic film. The proposed method was shown to be clinically viable, for using superficial HDR brachytherapy to overcome anatomical difficulties and create non-surgical treatments for BCC and SCC of the lower eyelid.
Collapse
Affiliation(s)
- H Stephens
- Chermside Medical Complex, Ground Floor, 956 Gympie Road, Chermside, Qld, 4032, Australia.
- School of Physical Sciences, University of Adelaide, North Terrace, Adelaide, SA, 5005, Australia.
| | - C Deans
- Chermside Medical Complex, Ground Floor, 956 Gympie Road, Chermside, Qld, 4032, Australia
- Icon Integrated Cancer Centre, 9 McLennan Ct, North Lakes, Qld, 4509, Australia
| | - D Schlect
- Chermside Medical Complex, Ground Floor, 956 Gympie Road, Chermside, Qld, 4032, Australia
| | - T Kairn
- Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Qld, 4029, Australia
- Science and Engineering Faculty, Queensland University of Technology, Gardens Point, Qld, 4001, Australia
| |
Collapse
|
2
|
Kim Y, Trombetta MG. Dosimetric evaluation of multilumen intracavitary balloon applicator rotation in high-dose-rate brachytherapy for breast cancer. J Appl Clin Med Phys 2014; 15:4429. [PMID: 24423837 PMCID: PMC5711249 DOI: 10.1120/jacmp.v15i1.4429] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2013] [Revised: 09/19/2013] [Accepted: 08/22/2013] [Indexed: 11/23/2022] Open
Abstract
The objective of this work is to evaluate dosimetric impact of multilumen balloon applicator rotation in high-dose-rate (HDR) brachytherapy for breast cancer. Highly asymmetrical dose distribution was generated for patients A and B, depending upon applicator proximity to skin and rib. Both skin and rib spacing was ≤ 0.7 cm for A; only rib spacing was ≤ 0.7 cm for B. Thirty-five rotation scenarios were simulated for each patient by rotating outer lumens every 10° over ± 180° range with respect to central lumen using mathematically calculated rotational matrix. Thirty-five rotated plans were compared with three plans: 1) original multidwell multilumen (MDML) plan, 2) multidwell single-lumen (MDSL) plan, and 3) single-dwell single-lumen (SDSL) plan. For plan comparison, planning target volume for evaluation (PTV_EVAL) coverage (dose to 95% and 90% volume of PTV_EVAL) (D95 and D90), skin and rib maximal dose (Dmax), and normal breast tissue volume receiving 150% (V150) and 200% (V200) of prescribed dose (PD) were evaluated. Dose variation due to device rotation ranged from -5.6% to 0.8% (A) and -6.5% to 0.2% (B) for PTV_EVAL D95; -5.2% to 0.4% (A) and -4.1% to 0.7% (B) for PTV_EVAL D90; -2.0 to 18.4% (A) and -7.8 to 17.5% (B) for skin Dmax; -11.1 to 22.8% (A) and -4.7 to 55.1% (B) of PD for rib Dmax, respectively. Normal breast tissue V150 and V200 variation was < 1.0 cc, except for -0.1 to 2.5cc (B) of V200. Furthermore, 30° device rotation increased rib Dmax over 145% of PD: 152.9% (A) by clockwise 30° rotation and 152.5% (B) by counterclockwise 30° rotation. For a highly asymmetric dose distribution, device rotation can outweigh the potential benefit of improved dose shaping capability afforded by multilumen and make dosimetric data worse than single-lumen plans unless it is properly corrected.
Collapse
|
3
|
Pearson D, Williams EA. Dose modification factor analysis of multilumen balloon brachytherapy applicator with Monte Carlo simulation. J Appl Clin Med Phys 2013; 15:54–62. [PMID: 24892326 PMCID: PMC5711056 DOI: 10.1120/jacmp.v15i3.4498] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2013] [Revised: 12/13/2013] [Accepted: 12/04/2013] [Indexed: 11/23/2022] Open
Abstract
The Contura brachytherapy applicator is a silicone balloon with five lumens in which a high-dose-rate brachytherapy source can traverse. Multilumen applicators, like the Contura, are used in accelerated partial breast irradiation (APBI) brachytherapy in instances where asymmetric dose distributions are desired; for example, when the applicator surface-to-skin thickness is small (< 7 mm). In these instances, the air outside the patient and the lung act as a poor scattering medium, scattering less dose back into the breast and affecting the dose distribution. The recent report by Task Group 186 of the American Association of Physicists in Medicine (AAPM) has outlined the importance of moving towards brachytherapy dose calculations using heterogeneity corrections. However, at this time, many commercial treatment planning systems do not correct for tissue heterogeneity, which can result in inaccuracies in the planned dose distribution. To quantify the deviation in the skin dose we utilize the dose modification factor (DMF), defined as the ratio of the dose rate at 1 cm beyond the applicator surface with homogenous medium, to the dose rate at 1 cm with heterogeneous medium. This investigation models the Contura applicator with the Monte Carlo N-Particle code version 5, and determines a DMF through simulation. Taking all geometrical considerations into account, an accurate model of the Contura balloon applicator was created in MCNP and used to run simulations. The dose modification factor was found to be only slightly dependent on whether the dose distribution was symmetric or asymmetric. These results indicate that the dose delivered to part of the PTV may be lower than the planned dose by up to 12%, and that these brachytherapy plans should be viewed with caution. In addition to studying the effects of backscatter, an evaluation was made regarding the capabilities of the Contura device to shape an asymmetric dose distribution. We compared these results to a previous study of a MammoSite ML and a SAVI device and found that the dose shaping capabilities of the Contura were quite similar to that of the MammoSite ML, but markedly inferior to the SAVI.
Collapse
|
4
|
Kim L, Narra V, Yue N. Heterogeneity-corrected vs -uncorrected critical structure maximum point doses in breast balloon brachytherapy. Med Dosim 2013; 38:196-8. [PMID: 23474368 DOI: 10.1016/j.meddos.2012.10.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2012] [Accepted: 10/30/2012] [Indexed: 10/27/2022]
Abstract
Recent studies have reported potentially clinically meaningful dose differences when heterogeneity correction is used in breast balloon brachytherapy. In this study, we report on the relationship between heterogeneity-corrected and -uncorrected doses for 2 commonly used plan evaluation metrics: maximum point dose to skin surface and maximum point dose to ribs. Maximum point doses to skin surface and ribs were calculated using TG-43 and Varian Acuros for 20 patients treated with breast balloon brachytherapy. The results were plotted against each other and fit with a zero-intercept line. Max skin dose (Acuros) = max skin dose (TG-43) * 0.930 (R(2) = 0.995). The average magnitude of difference from this relationship was 1.1% (max 2.8%). Max rib dose (Acuros) = max rib dose (TG-43) * 0.955 (R(2) = 0.9995). The average magnitude of difference from this relationship was 0.7% (max 1.6%). Heterogeneity-corrected maximum point doses to the skin surface and ribs were proportional to TG-43-calculated doses. The average deviation from proportionality was 1%. The proportional relationship suggests that a different metric other than maximum point dose may be needed to obtain a clinical advantage from heterogeneity correction. Alternatively, if maximum point dose continues to be used in recommended limits while incorporating heterogeneity correction, institutions without this capability may be able to accurately estimate these doses by use of a scaling factor.
Collapse
Affiliation(s)
- Leonard Kim
- Department of Radiation Oncology, Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08903-2681, USA.
| | | | | |
Collapse
|
5
|
Dose correction in lung for HDR breast brachytherapy. J Contemp Brachytherapy 2013; 4:106-10. [PMID: 23349652 PMCID: PMC3552632 DOI: 10.5114/jcb.2012.29367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2012] [Revised: 05/16/2012] [Accepted: 06/06/2012] [Indexed: 11/17/2022] Open
Abstract
Purpose To evaluate the dosimetric impact of lung tissue in Ir-192 APBI. Material and methods In a 40 × 40 × 40 cm3 water tank, an Accelerated Partial Breast Irradiation (APBI) brachytherapy balloon inflated to 4 cm diameter was situated directly below the center of a 30 × 30 × 1 cm3 solid water slab. Nine cm of solid water was stacked above the 1 cm base. A parallel plate ion chamber was centered above the base and ionization current measurements were taken from the central HDR source dwell position for channels 1, 2, 3 and 5 of the balloon. Additional ionization data was acquired in the 9 cm stack at 1 cm increments. A comparable data set was also measured after replacing the 9 cm solid water stack with cork slabs. The ratios of measurements in the two phantoms were calculated and compared to predicted results of a commercial treatment planning system. Results Lower dose was measured in the cork within 1 cm of the cork/solid water interface possibly due to backscatter effects. Higher dose was measured beyond 1 cm from the cork/solid water interface, increasing with path length up to 15% at 9 cm depth in cork. The treatment planning system did not predict either dose effect. Conclusions This study investigates the dosimetry of low density material when the breast is treated with Ir-192 brachytherapy. HDR dose from Ir-192 in a cork media is shown to be significantly different than in unit density media. These dose differences are not predicted in most commercial brachytherapy planning systems. Empirical models based on measurements could be used to estimate lung dose associated with HDR breast brachytherapy.
Collapse
|
6
|
Sung W, Kim S, Kim JI, Lee JG, Shin YJ, Jung JY, Ye SJ. Dosimetric perturbations due to an implanted cardiac pacemaker in MammoSite® treatment. Med Phys 2012; 39:6185-91. [DOI: 10.1118/1.4752088] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
|
7
|
Pacemaker/implantable cardioverter–defibrillator dose in balloon high-dose-rate brachytherapy for breast cancer treatment. Brachytherapy 2012; 11:380-6. [DOI: 10.1016/j.brachy.2012.01.001] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2011] [Revised: 12/30/2011] [Accepted: 01/02/2012] [Indexed: 01/01/2023]
|
8
|
Slessinger ED, Fletcher R, Das IJ. Dose perturbation study in a multichannel breast brachytherapy device. J Contemp Brachytherapy 2011; 3:220-3. [PMID: 23346131 PMCID: PMC3551364 DOI: 10.5114/jcb.2011.26473] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2011] [Revised: 11/20/2011] [Accepted: 12/07/2011] [Indexed: 11/17/2022] Open
Abstract
PURPOSE A study was conducted to determine the dosimetric effects resulting from air pockets and high atomic number (Z) contrast medium within a multichannel breast brachytherapy device. MATERIAL AND METHODS A 5-6 cm diameter Contura (SenoRx) brachytherapy device was inflated using 37 cm(3) of saline. Baseline dose falloff from an HDR Iridium-192 source was measured with the Iridium source centered in the central channel and an anterior off-center channel. Data were collected at distances from 1 to 50 mm. Comparison studies were conducted with identically inflated volume containing varied air pocket volumes (1-4 cm(3)) and concentrations of contrast solution (3%, 6%, and 9% by volume). Dose perturbation factors (DPF) were computed and evaluated. RESULTS Dose perturbations due to air pockets and contrast solutions were observed. As the volume of air increased, the DPF increased by approximately 2.25%/cm(3). The effect was consistent for both channels. The contrast effects were more complex. The 3% contrast media had minimal dose perturbation. The 6% contrast solution caused dose reduction of 1.0% from the central channel but 1.5% dose increase from the anterior channel. The 9% contrast solution caused dose reductions by 4.0% (from central channel) and 3.0% (from anterior channel). The DPF from all contrast solutions moderated with increasing distance. CONCLUSIONS Dose perturbations due to air pockets and high-Z contrast solution can be significant. It is important to control these effects to avoid dose errors.
Collapse
Affiliation(s)
- Eric D. Slessinger
- IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana
| | | | - Indra J Das
- IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana
| |
Collapse
|
9
|
Dose reduction study in vaginal balloon packing filled with contrast for HDR brachytherapy treatment. Int J Radiat Oncol Biol Phys 2010; 80:1263-7. [PMID: 20950949 DOI: 10.1016/j.ijrobp.2010.08.033] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2010] [Revised: 08/03/2010] [Accepted: 08/17/2010] [Indexed: 11/21/2022]
Abstract
PURPOSE Vaginal balloon packing is a means to displace organs at risk during high dose rate brachytherapy of the uterine cervix. We tested the hypothesis that contrast-filled vaginal balloon packing reduces radiation dose to organs at risk, such as the bladder and rectum, in comparison to water- or air-filled balloons. METHODS AND MATERIALS In a phantom study, semispherical vaginal packing balloons were filled with air, saline solution, and contrast agents. A high dose rate iridium-192 source was placed on the anterior surface of the balloon, and the diode detector was placed on the posterior surface. Dose ratios were taken with each material in the balloon. Monte Carlo (MC) simulations, by use of the MC computer program DOSXYZnrc, were performed to study dose reduction vs. balloon size and contrast material, including commercially available iodine- and gadolinium-based contrast agents. RESULTS Measured dose ratios on the phantom with the balloon radius of 3.4 cm were 0.922 ± 0.002 for contrast/saline solution and 0.808 ± 0.001 for contrast/air. The corresponding ratios by MC simulations were 0.895 ± 0.010 and 0.781 ± 0.010. The iodine concentration in the contrast was 23.3% by weight. The dose reduction of contrast-filled balloon ranges from 6% to 15% compared with water-filled balloon and 11% to 26% compared with air-filled balloon, with a balloon size range between 1.4 and 3.8 cm, and iodine concentration in contrast of 24.9%. The dose reduction was proportional to the contrast agent concentration. The gadolinium-based contrast agents showed less dose reduction because of much lower concentrations in their solutions. CONCLUSIONS The dose to the posterior wall of the bladder and the anterior wall of the rectum can be reduced if the vaginal balloon is filled with contrast agent in comparison to vaginal balloons filled with saline solution or air.
Collapse
|
10
|
Oh S, Scott J, Shin DH, Suh TS, Kim S. Measurements of dose discrepancies due to inhomogeneities and radiographic contrast in balloon catheter brachytherapy. Med Phys 2009; 36:3945-54. [PMID: 19810467 DOI: 10.1118/1.3183497] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Recently, a device called MammoSite, consisting of a balloon and a catheter, was developed to perform partial-breast irradiation using a high-dose-rate (HDR) brachytherapy unit with ease and reproducibility. However, the actual dose to the skin does not agree well with the calculated dose by the treatment planning system because of the difference between the calculation condition and the real treatment condition (i.e., homogeneous water and full scatter condition vs contrast solution and lack of full scatter condition). In this study, the authors experimentally estimated dose discrepancies due to contrast and lack of full scatter in breast HDR brachytherapy with MammoSite. Using metal-oxide-semiconductor field-effect transistor detectors and a breast phantom, the dose discrepancies between the calculation and the treatment conditions were measured according to contrast concentration (10% and 20% volume ratios), balloon size (35 and 60 cm3), and source to detector distance ranging from 25 to 50 mm. The source was an Ir-192 isotope from Nucletron HDR unit. The dose discrepancies from the calculation condition due to both contrast and lack of full scatter combined ranged from about -1.4 +/- 2.5% to -18.2 +/- 2.0% in the studied cases (error bound is in two sided confidence interval of 80% based on Student's t distribution). In all cases, the effect of lack of full scatter was dominant to that of contrast and significant dose discrepancies existed between the calculation and the real treatment conditions, indicating that the actual skin dose is less than that which is currently calculated.
Collapse
Affiliation(s)
- Seungjong Oh
- Department of Biomedical Engineering, The Catholic University of Korea, Seoul 137-701, Korea
| | | | | | | | | |
Collapse
|
11
|
A quantitative three-dimensional dose attenuation analysis around Fletcher-Suit-Delclos due to stainless steel tube for high-dose-rate brachytherapy by Monte Carlo calculations. Brachytherapy 2009; 8:318-23. [PMID: 19217355 DOI: 10.1016/j.brachy.2008.11.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2007] [Revised: 03/25/2008] [Accepted: 11/25/2008] [Indexed: 11/23/2022]
Abstract
PURPOSE The commercially available brachytherapy treatment-planning systems today, usually neglects the attenuation effect from stainless steel (SS) tube when Fletcher-Suit-Delclos (FSD) is used in treatment of cervical and endometrial cancers. This could lead to potential inaccuracies in computing dwell times and dose distribution. A more accurate analysis quantifying the level of attenuation for high-dose-rate (HDR) iridium 192 radionuclide ((192)Ir) source is presented through Monte Carlo simulation verified by measurement. METHODS AND MATERIALS In this investigation a general Monte Carlo N-Particles (MCNP) transport code was used to construct a typical geometry of FSD through simulation and compare the doses delivered to point A in Manchester System with and without the SS tubing. A quantitative assessment of inaccuracies in delivered dose vs. the computed dose is presented. In addition, this investigation expanded to examine the attenuation-corrected radial and anisotropy dose functions in a form parallel to the updated AAPM Task Group No. 43 Report (AAPM TG-43) formalism. This will delineate quantitatively the inaccuracies in dose distributions in three-dimensional space. The changes in dose deposition and distribution caused by increased attenuation coefficient resulted from presence of SS are quantified using MCNP Monte Carlo simulations in coupled photon/electron transport. The source geometry was that of the Vari Source wire model VS2000. The FSD was that of the Varian medical system. In this model, the bending angles of tandem and colpostats are 15 degrees and 120 degrees , respectively. We assigned 10 dwell positions to the tandem and 4 dwell positions to right and left colpostats or ovoids to represent a typical treatment case. Typical dose delivered to point A was determined according to Manchester dosimetry system. RESULTS AND CONCLUSIONS Based on our computations, the reduction of dose to point A was shown to be at least 3%. So this effect presented by SS-FSD systems on patient dose is of concern.
Collapse
|